+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Migraine Drug"

Analgesics - Global Strategic Business Report - Product Thumbnail Image

Analgesics - Global Strategic Business Report

  • Report
  • April 2026
  • 482 Pages
  • Global
From
Acute Migraine Treatment Market Report 2026 - Product Thumbnail Image

Acute Migraine Treatment Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
Digital Therapeutics Migraine Market Report 2026 - Product Thumbnail Image

Digital Therapeutics Migraine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Digital Therapeutics for Migraine Market Report 2026 - Product Thumbnail Image

Digital Therapeutics for Migraine Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Pain Management Drugs Market Outlook, 2030 - Product Thumbnail Image

Pain Management Drugs Market Outlook, 2030

  • Report
  • November 2025
  • 203 Pages
  • Global
From
Loading Indicator

The Migraine Drug market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Migraine drugs are used to treat the symptoms of migraine headaches, such as nausea, vomiting, and sensitivity to light and sound. These drugs can be divided into two categories: abortive and preventive. Abortive drugs are taken at the onset of a migraine attack to reduce the severity of symptoms, while preventive drugs are taken on a regular basis to reduce the frequency of migraine attacks. Common abortive drugs include triptans, ergot alkaloids, and non-steroidal anti-inflammatory drugs (NSAIDs). Common preventive drugs include beta-blockers, anticonvulsants, and serotonin receptor agonists. Some companies in the Migraine Drug market include GlaxoSmithKline, Pfizer, Novartis, Merck, and Allergan. Show Less Read more